Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044202237> ?p ?o ?g. }
- W3044202237 endingPage "663" @default.
- W3044202237 startingPage "652" @default.
- W3044202237 abstract "Abstract Human T-lymphotropic virus type 1 (HTLV-1) is associated with adult T cell leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HAM/TSP is an inflammatory disease of the spinal cord and clinically characterized by progressive spastic paraparesis, urinary incontinence, and mild sensory disturbance. The interaction between the host immune response and HTLV-1-infected cells regulates the development of HAM/TSP. HTLV-1 preferentially infects CD4 + T cells and is maintained by proliferation of the infected T cells. HTLV-1-infected cells rarely express viral antigens in vivo; however, they easily express the antigens after short-term culture. Therefore, such virus-expressing cells may lead to activation and expansion of antigen-specific T cell responses. Infected T cells with HTLV-1 and HTLV-1-specific CD8 + cytotoxic T lymphocytes invade the central nervous system and produce various proinflammatory cytokines and chemokines, leading to neuronal damage and degeneration. Therefore, cellular immune responses to HTLV-1 have been considered to play important roles in disease development of HAM/TSP. Recent studies have clarified the viral strategy for persistence in the host through genetic and epigenetic changes by HTLV-1 and host immune responses including T cell function and differentiation. Newly developed animal models could provide the opportunity to uncover the precise pathogenesis and development of clinically effective treatment. Several molecular target drugs are undergoing clinical trials with promising efficacy. In this review, we summarize recent advances in the immunopathogenesis of HAM/TSP and discuss the perspectives of the research on this disease." @default.
- W3044202237 created "2020-07-29" @default.
- W3044202237 creator A5035375413 @default.
- W3044202237 creator A5051578610 @default.
- W3044202237 creator A5066849672 @default.
- W3044202237 date "2020-07-23" @default.
- W3044202237 modified "2023-09-27" @default.
- W3044202237 title "Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis" @default.
- W3044202237 cites W1505665725 @default.
- W3044202237 cites W1531198730 @default.
- W3044202237 cites W1572140139 @default.
- W3044202237 cites W1577954990 @default.
- W3044202237 cites W1843667952 @default.
- W3044202237 cites W1957782439 @default.
- W3044202237 cites W1966278500 @default.
- W3044202237 cites W1973852185 @default.
- W3044202237 cites W1974439805 @default.
- W3044202237 cites W1978390898 @default.
- W3044202237 cites W1978629922 @default.
- W3044202237 cites W1983121621 @default.
- W3044202237 cites W1984903732 @default.
- W3044202237 cites W1985009440 @default.
- W3044202237 cites W1985830812 @default.
- W3044202237 cites W1989840044 @default.
- W3044202237 cites W1990691343 @default.
- W3044202237 cites W1991941671 @default.
- W3044202237 cites W1992302496 @default.
- W3044202237 cites W1996809486 @default.
- W3044202237 cites W1999036331 @default.
- W3044202237 cites W2003276121 @default.
- W3044202237 cites W2006211307 @default.
- W3044202237 cites W2008383971 @default.
- W3044202237 cites W2014251742 @default.
- W3044202237 cites W2016837741 @default.
- W3044202237 cites W2018420273 @default.
- W3044202237 cites W2023730860 @default.
- W3044202237 cites W2028883349 @default.
- W3044202237 cites W2029277444 @default.
- W3044202237 cites W2031094596 @default.
- W3044202237 cites W2034852475 @default.
- W3044202237 cites W2036818178 @default.
- W3044202237 cites W2037625695 @default.
- W3044202237 cites W2048443185 @default.
- W3044202237 cites W2051218111 @default.
- W3044202237 cites W2051266211 @default.
- W3044202237 cites W2055154478 @default.
- W3044202237 cites W2069667541 @default.
- W3044202237 cites W2070743897 @default.
- W3044202237 cites W2071794490 @default.
- W3044202237 cites W2074788975 @default.
- W3044202237 cites W2075715912 @default.
- W3044202237 cites W2076165333 @default.
- W3044202237 cites W2077677492 @default.
- W3044202237 cites W2084714153 @default.
- W3044202237 cites W2085122076 @default.
- W3044202237 cites W2085746138 @default.
- W3044202237 cites W2086143621 @default.
- W3044202237 cites W2087631303 @default.
- W3044202237 cites W2088302586 @default.
- W3044202237 cites W2092834432 @default.
- W3044202237 cites W2094236991 @default.
- W3044202237 cites W2096894434 @default.
- W3044202237 cites W2099491680 @default.
- W3044202237 cites W2100446341 @default.
- W3044202237 cites W2110018477 @default.
- W3044202237 cites W2110864759 @default.
- W3044202237 cites W2111095638 @default.
- W3044202237 cites W2115129006 @default.
- W3044202237 cites W2116147619 @default.
- W3044202237 cites W2122351983 @default.
- W3044202237 cites W2123524329 @default.
- W3044202237 cites W2123536328 @default.
- W3044202237 cites W2126328408 @default.
- W3044202237 cites W2133182368 @default.
- W3044202237 cites W2134594325 @default.
- W3044202237 cites W2137681991 @default.
- W3044202237 cites W2138952238 @default.
- W3044202237 cites W2144063967 @default.
- W3044202237 cites W2147813475 @default.
- W3044202237 cites W2149377687 @default.
- W3044202237 cites W2154664865 @default.
- W3044202237 cites W2162866571 @default.
- W3044202237 cites W2165581366 @default.
- W3044202237 cites W2169880136 @default.
- W3044202237 cites W2171479458 @default.
- W3044202237 cites W2185768551 @default.
- W3044202237 cites W2232289632 @default.
- W3044202237 cites W2256898151 @default.
- W3044202237 cites W2291064854 @default.
- W3044202237 cites W2313614613 @default.
- W3044202237 cites W2334930037 @default.
- W3044202237 cites W2395999798 @default.
- W3044202237 cites W2403151371 @default.
- W3044202237 cites W2406612864 @default.
- W3044202237 cites W2472765017 @default.
- W3044202237 cites W2509610441 @default.
- W3044202237 cites W2526675827 @default.
- W3044202237 cites W2546178653 @default.